Cladribine EP Impurity A
| Product Name | Cladribine EP Impurity A |
|---|---|
| Alternate Names | Cladribine Impurities, Impurities of Cladribine |
| CAT No. | CS-T-52425 |
| CAS No. | 4546-70-7 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 266.26 g/mol |
| Mol. For. | C₁₀H₁₄N₆O₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Cladribine |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | NC1=NC(N)=C2N=CN([C@@H]3C[C@@H]([C@@H](CO)O3)O)C2=N1 |
| Canonical Smiles | C1C(C(OC1N2C=NC3=C(N=C(N=C32)N)N)CO)O |
| InchIKey | NOLHIMIFXOBLFF-KVQBGUIXSA-N |
| Inchl | InChI=1S/C10H14N6O3/c11-8-7-9(15-10(12)14-8)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H4,11,12,14,15)/t4-,5+,6+/m0/s1 |
| IUPAC | (2R,3S,5R)-5-(2,6-diaminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-ol |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Cladribine, also known as 2-chlorodeoxyadenosine, is a chemotherapy drug used in the treatment of certain types of cancer, including hairy cell leukemia and multiple sclerosis. Cladribine EP Impurity A is a chemical impurity that can be found in small quantities in Cladribine.
The chemical formula of Cladribine EP Impurity A is C10H12ClN5O3, which indicates that it contains carbon, hydrogen, nitrogen, oxygen, and chlorine atoms. This impurity has a molecular weight of 287.7 g/mol and a melting point of approximately 229-231°C.
Although Cladribine EP Impurity A is not the main active ingredient in Cladribine, it is important to monitor its presence and concentration as it can affect the efficacy and safety of the drug. The impurity can be formed during the synthesis of Cladribine or during storage and handling of the drug.
To ensure the purity and quality of Cladribine, pharmaceutical manufacturers must adhere to strict guidelines and regulations set forth by regulatory agencies such as the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA). These guidelines require the testing and monitoring of impurities such as Cladribine EP Impurity A to ensure that the drug is safe and effective for use in patients.
Get an Instant Quote
Related Compounds
Cladribine 5′-(4-methylbenzoate) | Cladribine-13C5 | Cladribine EP Impurity B | Cladribine Mono Benzoate Impurity | Cladribine Impurity F | Cladribine Impurity E | Cladribine Impurity 1 | Cladribine Impurity D |